Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Options

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Nov 26, 2023 9:54pm

133 Views

Post# 35753776

RE:RE:RE:RE:RE:Options

Oh I do agree that they will all have the extra shares before expiry as there is no way that they would give away free money....My only point is and should be a no brainer is that they do not sell any shares until at least a partnership ( a worthy partnership for shareholders) is signed and sealed and that is the only way that anyone should have any respect for them IMO only.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing